Ayurvita Healthcare Launches The Revolutionary Cancer-Fighting Supplement On Its 11th Anniversary

This year we are gloriously stepping into the 11^th year of serving humankind with our products and services. We take this opportunity to announce the launch of a revolutionary Cancer Fighting supplement “RaproCell”. RaproCell is a result of years of research & development of Optimal Research U.S.A. With a Strategic alliance with Optimal Health Research U.S.A., Ayurvita Healthcare Pvt. Ltd. has acquired global licence for manufacturing & marketing of “RaproCell” in India and globally. Along with RaproCell & various Ayurvedic products Ayurvita Healthcare is entering into the open market (traditional) via OTC and Ethical platforms worldwide.

About RaproCell

This Cancer-Fighting supplement- RaproCell, is effective in improving the health of the patient in various types of cancer. It is shown to reduce side-effects when used as an adjuvant therapy to chemotherapy sessions and increases serum levels of vitamins and minerals in the patients with low serum levels and prone to life-threatening diseases. Clinical trials for this supplement were successfully conducted under FDA approved IRB, U.S.A. and they involved patients with cancers of breast, prostate, brain, spleen etc. This product will bring about a major radical change in the healthcare of patients suffering from deadly diseases.

The enhanced formula of RaproCell is formulated with ingredients like: –

• Antioxidants
• Vitamins
• Minerals
• Amino Acids
• Herbal Detox

This formulation provides just the right nutrients required by the body to heal from within and fight the root cause of the disease.

RaproCell gives the patients miraculous results with only one condition that they maintain a healthy diet and lifestyle throughout the treatment. This adoption of a healthy diet will not only help the supplement to better absorb in the body but it will also show the desired positive results sooner. A study at NIH proved that patients taking this supplement experiences an overall serum increase of 31.1% at three months. This increase was consistent over the range of testing.

Clinical trials

In the structured clinical trials, we saw significant reduction in tumour growth with virtually no negative side-effects. These clinical trials were conducted with patients diagnosed with prostate,

breast, colon, liver, lung, brain, and bone cancer. During the clinical trial using the product as adjunctive therapy with chemo and/or radiation, we saw an increased survival rate in the patients and a reduction of side effects from chemo and/or radiation to zero.

When patients with advanced cancer receive the nutritional support, they experienced:

• Lesser side effect
• Reduced risk of infection
• Reduced asthenia (Abnormal physical weakness or lack of energy)
• Improved well-

The basic concept of action mechanism of this supplement is that blocking the key protein, ATP (Adenosine Triphosphate) synthase, kills cancer cells.

         

With this miraculous supplement we seek to make a significant progress in the healthcare of humankind.

Founder   Dr Vijay Pratap Kushvaha

Dr Kushvaha’s status and reputation as an Ayurvedic healer are quite renowned with his impressive ability to cure illnesses when all other treatments have failed. He received his B.A.M.S [BACHELOR OF AYURVEDIC MEDICINE AND SURGERY] from Mumbai University and Medical International Practitioner (MIP) Australia. Dr Kushvaha has been practising Ayurveda for more than three decades.

As an innovator born with entrepreneurial skills, he reveals the world of the ‘science of life’ through the chain of “Dr Kushvaha’s Ayurveda Clinics” across the country.

One of his specialities is Pulse Diagnosis (Nadi-Pariksha), Dr Kushvaha, has profound understanding of human nature and thorough knowledge of physiology and Ayurvedic medicine. He is one the most

widely-travelled Ayurvedic doctor, having visited over 20 countries to offer consultations and lectures.

Dr Kushvaha has served as Research Assistant in Lifeline Medical Research Foundation, Mumbai. He has also appeared as visiting lecturer and consultant at Maharishi European Research University, Vlodrop, Holland, Kushal Wellness Centre, London U.K, and Perola International, Denhaag, Holland.

Dr Steven Osguthorpe

Dr S. Osguthorpe, ND, ABAAHP, is a fellow in menopausal endocrinology and anti-aging, regenerative and functional medicine, a former Special Forces Medic in Vietnam, US Alpine Masters Ski Racer, Mountain Climber and Pilot.

Dr Osguthorpe spent the last two decades researching anti-aging, cancer, and Lyme Disease, producing several effective formulas.

He is the Principal Protocol Investigator for the following Clinical Studies:

• Effectiveness of the Asyra in Assessing sub-physiologic Thyroid Levels in Women 35 to 65 years of
• Clinical diagnosis of Allergy antigens using Asyra
• Bio-identical Hormone Replacement for alleviating Postpartum Depression
• Effectiveness of elevated FT3 in reversing Chronic
• Eradication of prostate cancer using an ATP
• Eradication of malignant carcinoma in the breast tissue using an ATP inhibitor
• Countering chronic Lyme disease using ATP